Dehui Huang

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders

Moli Fan, Wei Qiu, Bitao Bu et al. · Neurology Neuroimmunology & Neuroinflammation · 2020 · 88 citations · Full text

Contribution of Gray and White Matter Abnormalities to Cognitive Impairment in Multiple Sclerosis

Xiaofei Zhang, Fangfang Zhang, Dehui Huang et al. · International Journal of Molecular Sciences · 2016 · 54 citations · Full text

Neuropsychology, Selective Gm Atrophy, White Matter +16

Quantitative radiomic biomarkers for discrimination between neuromyelitis optica spectrum disorder and multiple sclerosis

Xiaoxiao Ma, Liwen Zhang, Dehui Huang et al. · Journal of Magnetic Resonance Imaging · 2018 · 33 citations

The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica

Yang Yang, Dehui Huang, Weiping Wu et al. · Journal of Clinical Neuroscience · 2012 · 29 citations

Aquaporin-4 Antibodies, Autoimmune Disease, Ophthalmology +10